Abnormalities of Serotonin Metabolism and Their Relation to Symptoms in Untreated Celiac Disease

Clinical Gastroenterology and Hepatology

Volumn 4, Issue 7, 2006, Pages 874-881

  Coleman, Nicholas S ^a   Foley, Stephen ^a   Dunlop, Simon P ^a   Wheatcroft, Johanna ^a   Blackshaw, Elaine ^b   Perkins, Alan C ^b   Singh, Gulzar ^c   Marsden, Charles A ^c   Holmes, Geoffrey K ^d   Spiller, Robin C ^a  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^b Department of Medical Physics ^*  (United Kingdom)

^c UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^d DERBYSHIRE ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; SEROTONIN;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BIOAVAILABILITY; CARBOHYDRATE DIET; CELIAC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIARRHEA; DISEASE ASSOCIATION; DUODENUM BIOPSY; DYSPEPSIA; ENTEROCHROMAFFIN CELL; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATION; MALE; MEAL; NAUSEA; POSTPRANDIAL STATE; QUESTIONNAIRE; SEROTONIN BLOOD LEVEL; SEROTONIN METABOLISM; STATISTICAL SIGNIFICANCE; VOMITING;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CELIAC DISEASE; DUODENUM; DYSPEPSIA; FEMALE; HUMANS; HYDROXYINDOLEACETIC ACID; INTESTINAL MUCOSA; MALE; MIDDLE AGED; POSTPRANDIAL PERIOD; SEROTONIN;

EID: 33745599094     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2006.04.017     Document Type: Article

References (45)

1. Cubeddu L.X., Hoffmann I.S., Fuenmayor N.T., et al. Changes in serotonin metabolism in cancer patients. its relationship to nausea and vomiting induced by chemotherapeutic drugs. Br J Cancer 66 (1992) 198-203
2. der Ohe M.R., Camilleri M., and Kvols L.K. A 5HT3 antagonist corrects the postprandial colonic hypertonic response in carcinoid diarrhea. Gastroenterology 106 (1994) 1184-1189
3. Tonini M., Candura S.M., Messori E., et al. Therapeutic potential of drugs with mixed 5-HT4 agonist/5-HT3 antagonist action in the control of emesis. Pharmacol Res 31 (1995) 257-260
4. Cremonini F., Delgado-Aros S., and Camilleri M. Efficacy of alosetron in irritable bowel syndrome. a meta-analysis of randomized controlled trials. Neurogastroenterol Motil 15 (2003) 79-86
5. Spiller R.C., Jenkins D., Thornley J.P., et al. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 47 (2000) 804-811
6. Spiller R.C. Postinfectious irritable bowel syndrome. Gastroenterology 124 (2003) 1662-1671
7. Dunlop S.P., Jenkins D., Neal K.R., et al. Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. Gastroenterology 125 (2003) 1651-1659
8. Dunlop S.P., Coleman N., Perkins A.C., et al. Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome. Clin Gastroenterol Hepatol 3 (2005) 349-357
9. Houghton L.A., Foster J.M., and Whorwell P.J. Alosetron, a 5-HT3 receptor antagonist, delays colonic transit in patients with irritable bowel syndrome and healthy volunteers. Aliment Pharmacol Ther 14 (2000) 775-782
10. Wheatcroft J., McNaulty W., Jenkins D., et al. Relationship between inflammatory response and long term entero-endocrine cell hyperplasia following infection with Trichinella spiralis. effect of corticosteroids. Gastroenterology 124 (2003) A346
11. Sanders D.S., Carter M.J., Hurlstone D.P., et al. Association of adult coeliac disease with irritable bowel syndrome. a case-control study in patients fulfilling ROME II criteria referred to secondary care. Lancet 358 (2001) 1504-1508
12. Benini L., Sembenini C., Salandini L., et al. Gastric emptying of realistic meals with and without gluten in patients with coeliac disease. Effect of jejunal mucosal recovery. Scand J Gastroenterol 36 (2001) 1044-1048
13. Usai P., Usai S.P., Lai M., et al. Autonomic dysfunction and upper digestive functional disorders in untreated adult coeliac disease. Eur J Clin Invest 27 (1997) 1009-1015
14. Challacombe D.N., Dawkins P.D., and Baker P. Increased tissue concentrations of 5-hydroxytryptamine in the duodenal mucosa of patients with coeliac disease. Gut 18 (1977) 882-886
15. Haverback B.J., and Davidson J.D. Serotonin and the gastrointestinal tract. Gastroenterology 35 (1958) 570-578
16. Sjolund K., and Nobin A. Increased levels of plasma 5-hydroxytryptamine in patients with coeliac disease. Scand J Gastroenterol 20 (1985) 304-308
17. Coleman N., Dunlop S.P., Singh G., et al. Different postprandial plasma 5HT responses to a solid versus liquid carbohydrate meal. Neurogastroenterol Motil 14 (2002) 603
18. Marsh M.N., and Crowe P.T. Morphology of the mucosal lesion in gluten sensitivity. Baillieres Clin Gastroenterol 9 (1995) 273-293
19. Talley N.J., Stanghellini V., Heading R.C., et al. Functional gastroduodenal disorders. Gut 45 Suppl 2 (1999) II37-II42
20. Dunlop S.P., Coleman N.S., Blackshaw E., et al. Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome. Clin Gastroenterol Hepatol 3 (2005) 349-357
21. Sjolund K., and Nobin A. Increased levels of plasma 5-hydroxytryptamine in patients with coeliac disease. Scand J Gastroenterol 20 (1985) 304-308
22. Lauffer J.M., Zhang T., and Modlin I.M. Review article. current status of gastrointestinal carcinoids. Aliment Pharmacol Ther 13 (1999) 271-287
23. Endo T., Minami M., Hirafuji M., et al. Neurochemistry and neuropharmacology of emesis-the role of serotonin. Toxicology 153 (2000) 189-201
24. Lordal M., Wallen H., Hjemdahl P., et al. Concentration-dependent stimulation of intestinal phase III of migrating motor complex by circulating serotonin in humans. Clin Sci (Colch) 94 (1998) 663-670
25. Sjolund K., Alumets J., Berg N.O., et al. Enteropathy of coeliac disease in adults. increased number of enterochromaffin cells in the duodenal mucosa. Gut 23 (1982) 42-48
26. Challacombe D.N., Brown G.A., Black S.C., et al. Increased excretion of 5-hydroxyindoleacetic acid in urine of children with untreated coeliac disease. Arch Dis Child 47 (1972) 442-445
27. Linden D.R., Chen J.X., Gershon M.D., et al. Serotonin availability is increased in mucosa of guinea pigs with TNBS-induced colitis. Am J Physiol 285 (2003) G207-G216
28. Siepler J.K., Ahlman B.H., Bhargava H.N., et al. A pharmacokinetic analysis of the vagal release of 5-hydroxytryptamine in the cat. J Neural Transm 47 (1980) 99-105
29. Lin H.C., and Chen J.H. Slowing of intestinal transit by fat depends on an ondansetron-sensitive, efferent serotonergic pathway. Neurogastroenterol Motil 15 (2003) 317-322
30. Spiller R.C., Trotman I.F., Adrian T.E., et al. Further characterisation of the 'ileal brake' reflex in man-effect of ileal infusion of partial digests of fat, protein, and starch on jejunal motility and release of neurotensin, enteroglucagon, and peptide YY. Gut 29 (1988) 1042-1051
31. Erspamer V., and Testini A. Observations on the release and turnover rate of 5-hydroxytryptamine in the gastrointestinal tract. J Pharm Pharmacol 11 (1959) 618-623
32. Pimparkar B.D., Senesky D., and Kalser M.H. Blood serotonin in nontropical sprue. Gastroenterology 40 (1961) 504-506
33. Houghton L.A., Atkinson W., Whitaker R.P., et al. Increased platelet depleted plasma 5-hydroxytryptamine concentration following meal ingestion in symptomatic female subjects with diarrhoea predominant irritable bowel syndrome. Gut 52 (2003) 663-670
34. Pussard E., Guigueno N., Adam O., et al. Validation of HPLC-amperometric detection to measure serotonin in plasma, platelets, whole blood, and urine. Clin Chem 42 (1996) 1086-1091
35. Chiaravalloti G., Marazziti D., Batistini A., et al. Platelet serotonin transporter in coeliac disease. Acta Paediatr 86 (1997) 696-699
36. Enerback L., Hallert C., and Norrby K. Raised 5-hydroxytryptamine concentrations in enterochromaffin cells in adult coeliac disease. J Clin Pathol 36 (1983) 499-503
37. El Salhy M., Danielsson A., Stenling R., et al. Colonic endocrine cells in inflammatory bowel disease. J Intern Med 242 (1997) 413-419
38. Lampert I.A., Thorpe P., van Noorden S., et al. Selective sparing of enterochromaffin cells in graft versus host disease affecting the colonic mucosa. Histopathology 9 (1985) 875-886
39. Challacombe D.N., Sandler M., and Southgate J. Decreased duodenal monoamine oxidase activity in coeliac disease. Arch Dis Child 46 (1971) 213-215
40. Coates M.D., Mahoney C.R., Linden D.R., et al. Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. Gastroenterology 126 (2004) 1657-1664
41. Houghton L.A., Atkinson W., Whitaker R.P., et al. Increased platelet depleted plasma 5-hydroxytryptamine concentration following meal ingestion in symptomatic female subjects with diarrhoea predominant irritable bowel syndrome. Gut 52 (2003) 663-670
42. Bearcroft C.P., Perrett D., and Farthing M.J. Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome. a pilot study. Gut 42 (1998) 42-46
43. Coleman N.S., Marciani L., Blackshaw E., et al. Effect of a novel 5-HT3 receptor agonist MKC-733 on upper gastrointestinal motility in humans. Aliment Pharmacol Ther 18 (2003) 1039-1048
44. Ladabaum U., Brown M.B., Pan W., et al. Effects of nutrients and serotonin 5-HT3 antagonism on symptoms evoked by distal gastric distension in humans. Am J Physiol 280 (2001) G201-G208
45. Raybould H.E., Glatzle J., Robin C., et al. Expression of 5-HT3 receptors by extrinsic duodenal afferents contribute to intestinal inhibition of gastric emptying. Am J Physiol 284 (2003) G367-G372